Search

Bio-Rad Laboratories Inc

Gesloten

SectorGezondheidszorg

314.01 -1.08

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

312.44

Max

316.23

Belangrijke statistieken

By Trading Economics

Inkomsten

-731M

-11M

Verkoop

-101M

592M

K/W

Sectorgemiddelde

50.317

62.58

EPS

1.89

Winstmarge

-1.858

Werknemers

7,450

EBITDA

-751M

-637M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-4.07% downside

Dividenden

By Acuity

Volgende Winsten

4 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

322M

8.1B

Vorige openingsprijs

315.09

Vorige sluitingsprijs

314.01

Nieuwssentiment

By Acuity

50%

50%

146 / 340 Rangschikking in Healthcare

Bio-Rad Laboratories Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 jul 2026, 19:11 UTC

Bio Rad Laboratories Inc shares are lower, impacted by declines in the Life Sciences Tools & Services sub-sector. Earlier, they rebounded from a session low.

23 jul 2026, 20:03 UTC

Correlated Moves

Bio Rad Laboratories Inc shares are higher, supported by gains in the Life Sciences Tools & Services sector and positive sentiment from Thermo Fisher Scientific Inc.

22 jul 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are higher today, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

21 jul 2026, 16:26 UTC

News

Bio-Rad Laboratories Inc shares are lower amid negative sentiment surrounding Sartorius, which reported disappointing earnings from Danaher’s bioprocessing unit.

20 jul 2026, 19:17 UTC

Correlated Moves

BIO shares lower; iShares U.S. Healthcare ETF declines during session.

Peer Vergelijking

Prijswijziging

Bio-Rad Laboratories Inc Prognose

Koersdoel

By TipRanks

-4.07% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 301.67 USD  -4.07%

Hoogste 320 USD

Laagste 275 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bio-Rad Laboratories Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Sentiment

By Acuity

146 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
help-icon Live chat